Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 USD | -1.08% |
|
+12.96% | -87.57% |
24/06 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
21/06 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.57% | 124M | |
+2.97% | 94.74B | |
-4.08% | 37.28B | |
-13.26% | 32.68B | |
+74.27% | 27.72B | |
-11.58% | 16.19B | |
-1.66% | 13.88B | |
-11.67% | 11.58B | |
+190.36% | 10.92B | |
-52.61% | 9.54B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Amylyx Pharmaceuticals to Discontinue Relyvrio/Albrioza in US, Canada; Slashes Workforce by 70%